pSivida US, Inc. – Trademark Portfolio

Entity Type: 03

pSivida US, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DURASERT, EYEPOINT, EYEPOINT PHARMACEUTICALS, and DELIVERING INNOVATION TO THE EYE. The owner is based in Watertown, MA.

480 Pleasant St., Suite B300

Watertown, MA 02472

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

pSivida US, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (11 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does pSivida US, Inc. have?

pSivida US, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 abandoned, 1 cancelled.

What trademark classes does pSivida US, Inc. file in?

pSivida US, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are pSivida US, Inc.'s most well-known trademarks?

pSivida US, Inc.'s registered trademark portfolio includes well-known marks such as DURASERT, EYEPOINT, EYEPOINT PHARMACEUTICALS, and DELIVERING INNOVATION TO THE EYE. These are among 4 currently registered trademarks in the portfolio.

What is pSivida US, Inc.'s trademark registration success rate?

pSivida US, Inc. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.